Integrative Magnetic Resonance Imaging and Metabolomic Characterization of a Glioblastoma Rat Model
Brain Sciences · 23.04.2024 · 14 (5) · 409
DOI: 10.3390/brainsci14050409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Sciences, online erschienen am 23.04.2024. Verfasst von Nuria Arias-Ramos und 3 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigaciones Biomédicas Sols-Morreale, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), 280…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación, MICINN/AEI/FEDER, UE.
Abstract (Originalsprache)
Glioblastoma (GBM) stands as the most prevalent and lethal malignant brain tumor, characterized by its highly infiltrative nature. This study aimed to identify additional MRI and metabolomic biomarkers of GBM and its impact on healthy tissue using an advanced-stage C6 glioma rat model. Wistar rats underwent a stereotactic injection of C6 cells (GBM group, n = 10) or cell medium (sham group, n = 4). A multiparametric MRI, including anatomical T2W and T1W images, relaxometry maps (T2, T2*, and T1), the magnetization transfer ratio (MTR), and diffusion tensor imaging (DTI), was performed. Additionally, ex vivo magnetic resonance spectroscopy (MRS) HRMAS spectra were acquired. The MRI analysis revealed significant differences in the T2 maps, T1 maps, MTR, and mean diffusivity parameters between the GBM tumor and the rest of the studied regions, which were the contralateral areas of the GBM rats and both regions of the sham rats (the ipsilateral and contralateral). The ex vivo spectra revealed markers of neuronal loss, apoptosis, and higher glucose uptake by the tumor. Notably, the myo-inositol and phosphocholine levels were elevated in both the tumor and the contralateral regions of the GBM rats compared to the sham rats, suggesting the effects of the tumor on the healthy tissue. The MRI parameters related to inflammation, cellularity, and tissue integrity, along with MRS-detected metabolites, serve as potential biomarkers for the tumor evolution, treatment response, and impact on healthy tissue. These techniques can be potent tools for evaluating new drugs and treatment targets.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Instituto de Investigaciones Biomédicas Sols-Morreale, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), 28029 Madrid, Spain.
ORCID-Profile: Nuria Arias-Ramos, Cecilia Vieira, Pilar López-Larrubia
Förderung
- Ministerio de Ciencia e Innovación
- MICINN/AEI/FEDER, UE
Zitieren
APA
Arias-Ramos, N., Vieira, C., Pérez-Carro, R., & López-Larrubia, P. (2024). Integrative Magnetic Resonance Imaging and Metabolomic Characterization of a Glioblastoma Rat Model. Brain Sciences, 14(5), 409. https://doi.org/10.3390/brainsci14050409
Vancouver
Arias-Ramos N, Vieira C, Pérez-Carro R, López-Larrubia P. Integrative Magnetic Resonance Imaging and Metabolomic Characterization of a Glioblastoma Rat Model. Brain Sciences. 2024;14(5):409. doi:10.3390/brainsci14050409
BibTeX
@article{AriasRamos2024,
author = {Arias-Ramos, Nuria and Vieira, Cecilia and Pérez-Carro, Rocío and López-Larrubia, Pilar},
title = {Integrative Magnetic Resonance Imaging and Metabolomic Characterization of a Glioblastoma Rat Model},
journal = {Brain Sciences},
year = {2024},
volume = {14},
number = {5},
pages = {409},
doi = {10.3390/brainsci14050409}
}
EUVIMED